NDC 71288-407-01 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71288-407
- Requested NDC
- 71288-407-01
- Package NDCs from labels
- 71288-407-01, 71288-407-03, 71288-407-02, 71288-407-04
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Effective date
- 2022-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glycopyrrolate Injection, USP (For Intravenous or Intramuscular Use) | Meitheal Pharmaceuticals Inc. | 2022-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71288-407-01 | ML - Milliliter | 71288-407 | 4c47a772-d779-4d47-9d19-f726deb5fdbe | 1 | 2019-07-02 |
| 71288-407-02 | ML - Milliliter | 71288-407 | edda245a-7edf-4440-b044-4ba8a025597c | 1 | 2019-07-02 |
| 71288-407-03 | ML - Milliliter | 71288-407 | b7c17347-971c-4828-a67b-167383a23955 | 1 | 2019-07-02 |
| 71288-407-04 | ML - Milliliter | 71288-407 | 2784112e-0136-4112-a2e9-1c104c314f95 | 1 | 2019-07-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 95fbe384-eaff-1f2e-e053-2a95a90a0313 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f126596-7fbf-7a48-e053-2995a90abac7 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f12016d-9033-00b4-e053-2a95a90ad02a | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9c9666bf-841b-03fa-e053-2a95a90abb48 | 2023-05-11 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9e5113b7-1c0c-24bd-e053-2995a90ab94b | 2023-05-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | bbf0abe2-8deb-19b2-e053-2a95a90a60a3 | 2023-05-08 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | b622f21f-fa37-1259-e053-2995a90aa796 | 2023-05-04 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | a2a2a03f-21cc-5fec-e053-2995a90a84cb | 2023-05-03 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | LGM PHARMA SOLUTIONS, LLC | 392a969d-1e14-4ad8-835c-a47be4983067 | 2023-04-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | e8bb95ed-09f1-fcf1-e053-2a95a90a93e5 | 2023-04-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | ea4c8be4-a1e9-5901-e053-2995a90a5e63 | 2023-04-24 | Warnings, Adverse reactions | V92SO9WP2I |
| Crcle Fexofenadine Hydrochloride | FEXOFENADINE HYDROCHLORIDE | Innovus Pharmaceuticals, Inc. | f7784610-7ca5-4489-b391-f2b3f3f6549b | 2023-04-08 | Warnings | ANDA211075 |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Fexofenadine Hydrochloride | FEXOFENADINE HYDROCHLORIDE | Safrel Pharmaceuticals, LLC. | d6120f56-ab28-2696-e053-2995a90adf47 | 2023-03-28 | Warnings | ANDA211075 |
| BEVESPI AEROSPHERE | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | ae02436e-9528-490e-a844-0c0f6f2843f9 | 2023-03-24 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Civica, Inc. | 3ac4f32f-f5ca-4a6d-9bc7-2672d478b3d4 | 2023-03-01 | Warnings, Adverse reactions | V92SO9WP2I |
| NOVOLOG | INSULIN ASPART | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Allergy Relief | FEXOFENADINE HCL | CVS PHARMACY, INC | 57be0a69-9c5e-41a1-abd3-0b0e8a81093a | 2023-02-16 | Warnings | ANDA211075 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.